Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant for Pruritus in Plaque Psoriasis
NCT03343639Phase 2Completed
- Sponsor
- Vyne Therapeutics
- Start
- Nov 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of serlopitant in pruritus, sponsored by Vyne Therapeutics. Started Nov 2017; status: completed.
02
Drugs
serlopitant
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT03343639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03343639.